AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma

AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma

Despite a low risk of liver failure and preserved liver function, non-cirrhotic hepatocellular carcinoma (HCC) has a poor prognosis. In the current study, we evaluated an active regulator of SIRT1 (AROS) as a prognostic biomarker in non-cirrhotic HCC. mRNA levels of AROS were measured in tumor and n...

Full description

Bibliographic Details
Main Authors: Kwon, Jung-Hee, Ahn, Keun Soo, Moon, Young Ho, Park, Jin Young, Wang, Hee Jung, Choi, Kwan Yong, Kim, Gundo, Joh, Jae Won, Lee, Kyeong Geun, Kang, Koo Jeong
Format: Online
Language:English
Published: The Korean Academy of Medical Sciences 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553671/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553671/

Similar Items